🇰🇷 Praluent in South Korea

Praluent (ALIROCUMAB) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Praluent in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in South Korea

Frequently asked questions

Is Praluent approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Praluent in South Korea?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.